Back to Russell Investments Group, Ltd. Russell Investments Group, Ltd.

ARWRARWR

Showing 8 of 30 quarters

Position history for Russell Investments Group, Ltd.Russell Investments Group, Ltd.'s holdings in Arrowhead Pharmaceuticals, Inc.

Yes. Russell Investments Group holds 284,096 shares of ARWR (Arrowhead Pharmaceuticals), worth $23.2M, as of its Q2 2026 13F filing. It increased the position by 110,101 shares (+63.3%) from Q1 2026. Russell Investments Group has held ARWR since Q1 2019, across 30 quarterly 13F filings.

Current Value

$23.2M

Current Shares

284,096

Total Value Change

+$17M

Total Shares Change

-31,277

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
284,096
+63.3%
$23.2M0.0%$81.51
41
2026-Q1
Increased
173,995
+42.5%
$10.9M0.0%$62.70
37
2025-Q4
Increased
122,115
+847.8%
$8.1M0.0%$66.39
44
2025-Q3
Increased
12,884
+377.9%
$444,3920.0%$34.49
39
2025-Q2
Decreased
2,696
-52.1%
$42,5970.0%$15.80
0
2025-Q1
Decreased
5,629
-96.9%
$71,7250.0%$12.74
0
2024-Q4
Decreased
183,289
-41.9%
$3.4M0.0%$18.80
0
2024-Q3
Increased
315,373
+19.1%
$6.1M0.0%$19.37
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used